Learn how GLP‑1/GIP dual agonists like tirzepatide work at the molecular level to enhance insulin secretion, improve glucose control, and drive greater weight loss than GLP‑1 drugs alone. Explore mechanisms, incretin hormones, and key clinical trial results.
Learn how GLP‑1/GIP dual agonists work, their metabolic benefits, and why these next‑generation incretin peptide drugs are transforming treatment for obesity and type 2 diabetes with near‑surgical weight loss and powerful glucose control.